Description
HIGH DOSE FLU VACCINE FOR FLU SEASON 2012 AND 2013
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-05-14+$5,395= $5,395
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-05-14 | +$5,395 | $5,395 | HIGH DOSE FLU VACCINE FOR FLU SEASON 2012 AND 2013 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NCXBGGQ8YTU9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24626N0644 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $24,097 | FY2026 |
| 36C26026N0269 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $19,614 | FY2026 |
| 36C24526N0396 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,943 | FY2026 |
| 36C24526N0408 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $20,735 | FY2026 |
| 36C24526N0416 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $29,421 | FY2026 |
| 36C24526N0426 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $70,050 | FY2026 |
Other recipients under 6505 from 667-SHREVEPORT (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25614P3675 | PHARMACYCLICS, INC. | 667-SHREVEPORT | $24,429 | FY2014 |
| VA25613F1296 | SEQIRUS USA INC | 667-SHREVEPORT | $98,100 | FY2013 |
| VA25613F2557 | CEPHEID | 667-SHREVEPORT | $297,043 | FY2013 |
| VA25612F1886 | EUSA PHARMA (USA), INC. | 667-SHREVEPORT | $4,362 | FY2012 |
| VA25612P1759 | CARDINAL HEALTH 414, LLC | 667-SHREVEPORT | $3,274 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25612J1567_3600_VA797P12C0020_3600 · retrieved 2026-09-26.